Recurrent Adult Liver Carcinoma

7 clinical trials · Condition

Record	Firm	Date
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery (NCT02042443)	National Cancer Institute (NCI)	2014-02-01
MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery (NCT01425879)	National Cancer Institute (NCI)	2011-04-01
MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy (NCT01239355)	National Cancer Institute (NCI)	2010-12-01
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery (NCT01899261)	Montefiore Medical Center	2010-10-07
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (NCT01010126)	National Cancer Institute (NCI)	2009-09-08
Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer (NCT01008566)	National Cancer Institute (NCI)	2009-08-01
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery (NCT00608361)	National Cancer Institute (NCI)	2008-10-01

Every clearance here is in the API, with alerts when new ones post.